Outstanding Response in a Patient With ROS1-Rearranged Inflammatory Myofibroblastic Tumor of Soft Tissues Treated With Crizotinib: Case Report

Inflammatory myofibroblastic tumor (IMT) is a very rare subtype of sarcoma, which frequently harbor chromosomal rearrangements, including anaplastic lymphoma kinase (ALK) rearrangements (almost 50% of the IMTs) and other kinase fusions such as ROS1. ROS1 fusions are present in about 10% of IMT, almo...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Front Oncol
Prif Awduron: Comandini, Danila, Catalano, Fabio, Grassi, Massimiliano, Pesola, Guido, Bertulli, Rossella, Guadagno, Antonio, Spina, Bruno, Mascherini, Matteo, De Cian, Franco, Pistoia, Federico, Rebuzzi, Sara Elena
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Frontiers Media S.A. 2021
Pynciau:
Oncology
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8239351/
https://ncbi.nlm.nih.gov/pubmed/34211840
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.658327
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg